Investment analysts at StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a research report issued to clients and investors on Tuesday. The brokerage set a “hold” rating on the biotechnology company’s stock.
Calithera Biosciences Price Performance
CALA opened at $0.01 on Tuesday. The company has a 50-day moving average of $0.01 and a 200-day moving average of $0.02. Calithera Biosciences has a 1-year low of $0.01 and a 1-year high of $0.13.
About Calithera Biosciences
Featured Stories
- Five stocks we like better than Calithera Biosciences
- What Are Growth Stocks and Investing in Them
- Target Hits the Mark: Q2 Earnings Exceed Expectations
- Best Aerospace Stocks Investing
- Is Tesla’s Rebound Just Starting? Why You Should Consider Buying
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Stanley Druckenmiller’s Latest Bet: MELI—Should You Follow Suit?
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
